- Guggenheim Healthcare Talks |
Idea Forum | 3rd Annual Neuro/Immunology Day. Fireside chat onMonday, November 15, 2021 at9:40 a.m. ET . Evercore ISI 4th AnnualHealthCONx Conference . Fireside chat onTuesday, November 30, 2021 at12:35 p.m. ET .- Piper Sandler 33rd Annual Healthcare Conference. Pre-recorded fireside chat will be made available on
November 22, 2021 at10:00 a.m. ET .
Additional information regarding these events will be available on the Investors section of the argenx website at argenx.com/investors.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in
For further information, please contact:
Media:
kkirk@argenx.com
Joke Comijn (EU)
jcomijn@argenx.com
Investors:
bdelgiacco@argenx.com
mgreenblatt@argenx.com
Source: argenx SE
2021 GlobeNewswire, Inc., source